| Symbol | Company | Weighting |
|---|---|---|
| GH | GUARDANT HEALTH INC | 2.54% |
| ITCI | INTRA-CELLULAR THERAPIES USD | 2.44% |
| SMMT | SUMMIT THERAPEUTICS INC. | 2.10% |
| TNDM | TANDEM DIABETES CARE INC | 2.00% |
| NBIX | NEUROCRINE BIOSCIENCES INC | 1.96% |
| PEN | PENUMBRA INC | 1.95% |
| DXCM | DEXCOM INC | 1.94% |
| NAMS | NEWAMSTERDAM PHARMA CO NV | 1.94% |
| ISRG | INTUITIVE SURGICAL INC | 1.91% |
| TMO | THERMO FISHER SCIENTIFIC INC | 1.88% |
| TVTX | TRAVERE THERAPEUTICS INC | 1.87% |
| BSX | BOSTON SCIENTIFIC | 1.84% |
| GKOS | GLAUKOS CORPORATION | 1.84% |
| ARWR | ARROWHEAD PHARMACEUTICALS INC | 1.82% |
| SNY | SANOFI- AVENTIS- ADR | 1.81% |
| AXSM | AXSOME THERAPEUTICS INC. | 1.81% |
| ABT | ABBOTT LABORATORIES | 1.78% |
| AZN | ASTRAZENECA PLC-ADR | 1.78% |
| ARGX | ARGENX SE ADR | 1.77% |
| INSM | INSMED INC | 1.76% |
| ELV | ELEVANCE HEALTH INC | 1.75% |
| BDX | BECTON DICKINSON & CO | 1.73% |
| SYK | STRYKER CORP | 1.72% |
| PCVX | VAXCYTE INC | 1.72% |
| ALC | ALCON INC | 1.71% |
| LLY | ELI LILLY CORP | 1.70% |
| GEHC | GE HEALTHCARE TECHNOLOGIES INC | 1.70% |
| ASND | ASCENDIS PHARMA A/S DKK 1.0 ADR | 1.69% |
| CYTK | CYTOKINETICS INC | 1.67% |
| MOH | MOLINA HEALTHCARE INC | 1.67% |
| INSP | INSPIRE MEDICAL SYSTEMS, INC. | 1.65% |
| RMD | RESMED INC | 1.65% |
| ICLR | ICON PLC | 1.65% |
| BMRN | BIOMARIN PHARAMCEUTICAL INC | 1.62% |
| MRK | MERCK & CO. NEW | 1.62% |
| MCK | MCKESSON CORP | 1.62% |
| CNTA | CENTESSA PHARMACEUTI | 1.62% |
| HUM | HUMANA INC | 1.61% |
| COO | COOPER COS INC | 1.61% |
| MRUS | MERUS NV | 1.59% |
| RARE | ULTRAGENYX PHARMACEUTICAL INC | 1.57% |
| ZTS | ZOETIS INC | 1.57% |
| HCA | HCA HOLDINGS INC | 1.54% |
| BIIB | BIOGEN INC | 1.52% |
| IDYA | IDEAYA BIOSCIENCES, INC | 1.52% |
| NUVL | NUVALENT INC | 1.49% |
| THC | TENET HEALTHCARE CORP | 1.49% |
| SNDX | SYNDAX PHARMACEUTICALS, INC. | 1.47% |
| REGN | REGENERON PHARMACEUTICALS | 1.46% |
| EWTX | EDGEWISE THERAPEUTICS | 1.46% |
| UNH | UNITEDHEALTH GROUP INC | 1.45% |
| IMVT | IMMUNOVANT INC | 1.45% |
| CI | THE CIGNA GROUP | 1.44% |
| NVO | NOVO NORDISK A/S | 1.35% |
| ARVN | ARVINAS INC USD | 1.31% |
| GERN | GERON CORP | 1.24% |
| RVMD | REVOLUTION MEDICINES INC | 1.19% |
| IMTX | IMMATICS NV | 1.18% |
| AMLX | AMYLYX PHARMACEUTICALS INC | 1.13% |
| ABVX | ABIVAX SA | 1.13% |
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or call 800.820.0888.
Investing involves risk, including the possible loss of principal.
Guggenheim Investments represents the following affiliated investment management businesses of Guggenheim Partners, LLC: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Wealth Solutions, LLC, Guggenheim Partners Europe Limited, Guggenheim Partners Japan Limited, GS GAMMA Advisors, LLC, and Guggenheim Private Investments, LLC. Securities offered through Guggenheim Funds Distributors, LLC.
© 2025 Guggenheim Investments. All Rights Reserved.
Research our firm with FINRA Broker Check.
• Not FDIC Insured • No Bank Guarantee • May Lose Value
This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.